The DOI matches its Crossref record; 324 of the 324 references it cites were found in a registry or an index.
A delicate balance: Iron metabolism and diseases of the brain
Open accessAbstract
Iron is the most abundant transition metal within the brain, and is vital for a number of cellular processes including neurotransmitter synthesis, myelination of neurons, and mitochondrial function. Redox cycling between ferrous and ferric iron is utilized in biology for various electron transfer reactions essential to life, yet this same chemistry mediates deleterious reactions with oxygen that induce oxidative stress. Consequently, there is a precise and tightly controlled mechanism to regulate iron in the brain. When iron is dysregulated, both conditions of iron overload and iron deficiencies are harmful to the brain. This review focuses on how iron metabolism is maintained in the brain, and how an alteration to iron and iron metabolism adversely affects neurological function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yaşlı Kadınlarda Üreme Sağlığı
Kokanalı, D., & Engin Üstün, Y. (n.d.) · DergiPark (Istanbul University) · Cited by 170,090
Two new Later Stone Age sites from the Final Pleistocene in the Falémé Valley, eastern Senegal
Ndiaye, M., Lespez, L., Tribolo, C., Rassé, M., Hadjas, I., Davidoux, S., Huysecom, É., & Douze, K. (2024) · Monash University Research Portal (Monash University) · doi:10.3929/ethz-b-000667478 · Cited by 23,868
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Protein Misfolding, Functional Amyloid, and Human Disease
Chiti, F., & Dobson, C. M. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.101304.123901 · Cited by 6,423
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
Journal of Biological Chemistry
(2021) · Journal of Biological Chemistry · doi:10.1074/jbc · Cited by 3,400
Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion
Campuzano, V., Montermini, L., Moltò, M. D., Pianese, L., Cossée, M., Cavalcanti, F., Monros, E., Rodius, F., Duclos, F., Monticelli, A., et al. (1996) · Science · doi:10.1126/science.271.5254.1423 · Cited by 2,786 · cited 1×
“This autosomal recessive degenerative disease results from mutations in the mitochondrial protein frataxin (Campuzano et al., 1996; Carvajal et al., 1996).”
BackgroundOxidative stress and neurodegeneration: where are we now?
Halliwell, B. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03907.x · Cited by 2,614
Copper, iron and zinc in Alzheimer's disease senile plaques
Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., & Markesbery, W. R. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00092-6 · Cited by 2,120
Initiative, T. A. D. N., Hollingworth, P., CHARGE consortium, EADI1 consortium, Harold, D., Sims, R., Gerrish, A., Lambert, J.-C., Carrasquillo, M. M., Abraham, R., et al. (2011) · Nature Genetics · doi:10.1038/ng.803 · Cited by 1,997 · cited 1×
“…C2 positively correlates with AD risk with an OR of 1.21 (Bertram and Tanzi, 2008), which is supported by a number of independent studies (Van Landeghem et al., 1998; Schjeide et al., 2009; Kauwe et al., 2010) but was not confirmed in a recent largescale GWAS study (Hollingworth et al., 2011).”
ResultInfluentialThe Wilson disease gene is a putative copper transporting P–type ATPase similar to the Menkes gene
Bull, P. C., Thomas, G. R., Rommens, J. M., Forbes, J. R., & Cox, D. W. (1993) · Nature Genetics · doi:10.1038/ng1293-327 · Cited by 1,948
Yang, W. S., & Stockwell, B. R. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.02.010 · Cited by 1,876 · cited 1×
“This type of cell death pathway shared no markers of apoptosis (e.g., caspase activation, mitochondrial cytochrome c release), but could be prevented by iron chelation or iron uptake inhibition (Yagoda et al., 2007; Yang and Stockwell, 2008).”
BackgroundHentze, M. W., Muckenthaler, M. U., & Andrews, N. C. (2004) · Cell · doi:10.1016/s0092-8674(04)00343-5 · Cited by 1,736
RAS–RAF–MEK-dependent oxidative cell death involving voltage-dependent anion channels
Yagoda, N., von Rechenberg, M., Zaganjor, E., Bauer, A. J., Yang, W. S., Fridman, D. J., Wolpaw, A. J., Smukste, I., Peltier, J. M., Boniface, J. J., et al. (2007) · Nature · doi:10.1038/nature05859 · Cited by 1,631
Cherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y.-S., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00317-8 · Cited by 1,447 · cited 2×
“The therapeutic effects of clioquinol have often been attributed to its ionophore activity, which redistributes copper and zinc into the cell (Cherny et al., 2001; Nitzan et al., 2003; Adlard et al., 2008; Li et al., 2010; Crouch et al., 2011; Park et al., 2011).”
BackgroundSelf-citationIron accumulation in Alzheimer disease is a source of redox-generated free radicals
Smith, M. A., Harris, P. L. R., Sayre, L. M., & Perry, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9866 · Cited by 1,355
A review of studies on the effect of iron deficiency on cognitive development in children
Grantham-McGregor, S., & Ani, C. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.2.649s · Cited by 1,293
The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis
Donovan, A., Lima, C. A., Pinkus, J. L., Pinkus, G. S., Zon, L. I., Robine, S., & Andrews, N. C. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.01.003 · Cited by 1,275 · cited 1×
“Ferroportin allows ferrous iron to be transported out of the cell (Donovan et al., 2005), and this process requires a ferroxidase to oxidize the ferrous iron to ferric, so that Tf can bind the exported iron.”
BackgroundA Novel Mammalian Iron-regulated Protein Involved in Intracellular Iron Metabolism
Abboud, S., & Haile, D. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000713200 · Cited by 1,267
Prevalence of Iron Deficiency in the United States
Looker, A. C. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540360041028 · Cited by 1,222
pH and the recycling of transferrin during receptor-mediated endocytosis.
Dautry-Varsat, A., Ciechanover, A., & Lodish, H. F. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.8.2258 · Cited by 1,179
Dexter, D. T., Wells, F. R., Lee, A. J., Agid, F., Agid, Y., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07264.x · Cited by 1,149 · cited 1×
“…elevation within this nucleus has been consistently reported using multiple techniques such as inductively coupled plasma-mass spectrometry (ICPMS; Dexter et al., 1989; Lei et al., 2012), atomic absorption spectroscopy (Ayton et al., 2012b), X-ray fluorescence (Popescu et al., 2009), and MRI…”
MethodIron Biology in Immune Function, Muscle Metabolism and Neuronal Functioning
Beard, J. L. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.2.568s · Cited by 1,134
DEXTER, D. T., CARAYON, A., JAVOY-AGID, F., AGID, Y., WELLS, F. R., DANIEL, S. E., LEES, A. J., JENNER, P., & MARSDEN, C. D. (1991) · Brain · doi:10.1093/brain/114.4.1953 · Cited by 1,043 · cited 4×
“…supranuclear palsy (Coffey et al., 1989; Dexter et al., 1991; Boelmans et al., 2012), Pick’s disease (Ehmann et al., 1984), Huntington’s disease (Dexter et al., 1991; Bartzokis et al., 2007; Jurgens et al., 2010; Rosas et al., 2012), prion disorders (Singh et al., 2009a, 2012), amyotrophic…”
BackgroundInfluentialLong-term developmental outcome of infants with iron deficiency
Lozoff, B., Jimenez, E., & Wolf, A. W. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109053251004 · Cited by 1,009 · cited 1×
“…skills, visual-motor integration, language and global IQ, accompanying higher scores in anxiety and depression, social and attention problems (Palti et al., 1985; Lozoff et al., 1991; Hurtado et al., 1999) with some symptoms persisting 10 years after treatment for anemia (Lozoff et al., 2000).”
BackgroundRitchie, C. W., Bush, A. I., Mackinnon, A., Macfarlane, S., Mastwyk, M., MacGregor, L., Kiers, L., Cherny, R., Li, Q.-X., Tammer, A., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.12.1685 · Cited by 988
Self-citationHIF-1 and human disease: one highly involved factor
Semenza, G. L. (2000) · Genes & Development · doi:10.1101/gad.14.16.1983 · Cited by 909 · cited 1×
“…(cAMP) response element-binding protein Frontiers in Aging Neuroscience www.frontiersin.org July 2013 | Volume 5 | Article 34 | 4 “fnagi-05-00034” — 2013/7/16 — 20:30 — page 5 — #5 (CREB), which activates transcription of target genes with hypoxia response elements (HREs; Semenza, 2000).”
BackgroundLozoff, B., Jimenez, E., Hagen, J., Mollen, E., & Wolf, A. W. (2000) · Pediatrics · doi:10.1542/peds.105.4.e51 · Cited by 897
Ekbom, K. A. (1960) · Neurology · doi:10.1212/wnl.10.9.868 · Cited by 841
Chemistry and biology of eukaryotic iron metabolism
Aisen, P. (2001) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(01)00063-2 · Cited by 804
The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22
Camaschella, C., Roetto, A., Calì, A., De Gobbi, M., Garozzo, G., Carella, M., Majorano, N., Totaro, A., & Gasparini, P. (2000) · Nature Genetics · doi:10.1038/75534 · Cited by 803
Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses
Bertram, L., & Tanzi, R. E. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2494 · Cited by 747
Puccio, H., Simon, D., Cossée, M., Criqui-Filipe, P., Tiziano, F., Melki, J., Hindelang, C., Matyas, R., Rustin, P., & Koenig, M. (2001) · Nature Genetics · doi:10.1038/84818 · Cited by 738
Restless Legs Syndrome and Sleep Bruxism: Prevalence and Association Among Canadians
(1994) · Sleep · doi:10.1093/sleep/17.8.739 · Cited by 720
Altered Brain Metabolism of Iron as a Cause of Neurodegenerative Diseases?
Gerlach, M., Ben‐Shachar, D., Riederer, P., & Youdim, M. B. H. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63030793.x · Cited by 703
The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum.
Osaki, S., Johnson, D. A., & Frieden, E. (1966) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)96527-0 · Cited by 679 · cited 1×
“A possible alternative mechanism for the uptake of NTBI may be associated with the expression of ferroportin in the BBB (Wu et al., 2004) and circulating ferroxidases (enzymes that catalyze Fe2+ oxidation to Fe3+) like ceruloplasmin (Cp; Osaki et al., 1966).”
BackgroundDuce, J. A., Tsatsanis, A., Cater, M. A., James, S. A., Robb, E., Wikhe, K., Leong, S. L., Perez, K., Johanssen, T., Greenough, M. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.08.014 · Cited by 676
Self-citationAdlard, P. A., Cherny, R. A., Finkelstein, D. I., Gautier, E., Robb, E., Cortes, M., Volitakis, I., Liu, X., Smith, J. P., Perez, K., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.018 · Cited by 672
Self-citationPrevalence and risk factors of RLS in an elderly population: The MEMO Study
Rothdach, A. J., Trenkwalder, C., Haberstock, J., Keil, U., & Berger, K. (2000) · Neurology · doi:10.1212/wnl.54.5.1064 · Cited by 657
Molecular Cloning of Transferrin Receptor 2
Kawabata, H., Yang, R., Hirama, T., Vuong, P. T., Kawano, S., Gombart, A. F., & Koeffler, H. P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.30.20826 · Cited by 650
Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo
Kaur, D., Yantiri, F., Rajagopalan, S., Kumar, J., Mo, J. Q., Boonplueang, R., Viswanath, V., Jacobs, R., Yang, L., Beal, M. F., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00126-0 · Cited by 620
Self-citationAbnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome
Earley, C. J., Connor, J. R., Beard, J. L., Malecki, E. A., Epstein, D. K., & Allen, R. P. (2000) · Neurology · doi:10.1212/wnl.54.8.1698 · Cited by 616
Hereditary Hemochromatosis: Pathogenesis, Diagnosis, and Treatment
Pietrangelo, A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.013 · Cited by 615
Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export
Lei, P., Ayton, S., Finkelstein, D. I., Spoerri, L., Ciccotosto, G. D., Wright, D. K., Wong, B. X. W., Adlard, P. A., Cherny, R. A., Lam, L. Q., et al. (2012) · Nature Medicine · doi:10.1038/nm.2613 · Cited by 594 · cited 8×
“Clioquinol is a moderate affinity iron chelator that has undergone extensive pre-clinical testing for neurodegenerative disorders, and a clinical trial (Cherny et al., 2001; Kaur et al., 2003; Ritchie et al., 2003; Lei et al., 2012).”
BackgroundMethodResultInfluentialSelf-citationMRI measurement of brain iron in patients with restless legs syndrome
Allen, R. P., Barker, P. B., Wehrl, F., Song, H. K., & Earley, C. J. (2001) · Neurology · doi:10.1212/wnl.56.2.263 · Cited by 570
Rogers, J. T., Randall, J. D., Cahill, C. M., Eder, P. S., Huang, X., Gunshin, H., Leiter, L., McPhee, J., Sarang, S. S., Utsuki, T., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207435200 · Cited by 551 · cited 1×
“The mRNA of APP has an IRE in its 5′-UTR (Rogers et al., 2002, 2008), and was found to facilitate iron export in vitro and in vivo (Duce et al., 2010).”
BackgroundSelf-citationNeuropathological examination suggests impaired brain iron acquisition in restless legs syndrome
Connor, J. R., Boyer, P. J., Menzies, S. L., Dellinger, B., Allen, R. P., Ondo, W. G., & Earley, C. J. (2003) · Neurology · doi:10.1212/01.wnl.0000078887.16593.12 · Cited by 548 · cited 1×
“Direct measurements of iron by post-mortem histological staining (Connor et al., 2003) and MRI (Allen et al., 2001; Earley et al., 2006) reveal decreased levels in the substantia nigra (SN) of affected patients.”
BackgroundReceptor‐mediated transcytosis of transferrin across the blood‐brain barrier
Fishman, J. B., Rubin, J. B., Handrahan, J. V., Connor, J. R., & Fine, R. E. (1987) · Journal of Neuroscience Research · doi:10.1002/jnr.490180206 · Cited by 544
Sayre, L. M., Perry, G., Harris, P. L. R., Liu, Y., Schubert, K. A., & Smith, M. A. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0740270.x · Cited by 540
Curtis, A. R. J., Fey, C., Morris, C. M., Bindoff, L. A., Ince, P. G., Chinnery, P. F., Coulthard, A., Jackson, M. J., Jackson, A. P., McHale, D. P., et al. (2001) · Nature Genetics · doi:10.1038/ng571 · Cited by 537
Richardson, D. R., Lane, D. J. R., Becker, E. M., Huang, M. L.-H., Whitnall, M., Rahmanto, Y. S., Sheftel, A. D., & Ponka, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912925107 · Cited by 536
Iron Metabolism and the IRE/IRP Regulatory System: An Update
PANTOPOULOS, K. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.001 · Cited by 512
Zecca, L., Stroppolo, A., Gatti, A., Tampellini, D., Toscani, M., Gallorini, M., Giaveri, G., Arosio, P., Santambrogio, P., Fariello, R. G., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403495101 · Cited by 495
A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains
Connor, J. R., Menzies, S. L., St. Martin, S. M., & Mufson, E. J. (1992) · Journal of Neuroscience Research · doi:10.1002/jnr.490310111 · Cited by 467
The A53T α-Synuclein Mutation Increases Iron-Dependent Aggregation and Toxicity
Ostrerova-Golts, N., Petrucelli, L., Hardy, J., Lee, J. M., Farer, M., & Wolozin, B. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06048.2000 · Cited by 466
Mantyh, P. W., Ghilardi, J. R., Rogers, S., DeMaster, E., Allen, C. J., Stimson, E. R., & Maggio, J. E. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03639.x · Cited by 465
Regulation of iron acquisition and storage: consequences for iron-linked disorders
De Domenico, I., McVey Ward, D., & Kaplan, J. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2295 · Cited by 464 · cited 1×
“The newly freed Fe3+ is quickly reduced by the six-transmembrane epithelial antigen of prostate 1-4 (STEAP 1-4), allowing export from the endosome into the cytosol by DMT1 (De Domenico et al., 2008).”
BackgroundIron trafficking inside the brain
Moos, T., Nielsen, T. R., Skjørringe, T., & Morgan, E. H. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04976.x · Cited by 420
Striatal dopaminergic function in restless legs syndrome: 18F-dopa and11C-raclopride PET studies
Turjanski, N., Lees, A. J., & Brooks, D. J. (1999) · Neurology · doi:10.1212/wnl.52.5.932 · Cited by 416
Salazar, J., Mena, N., Hunot, S., Prigent, A., Alvarez-Fischer, D., Arredondo, M., Duyckaerts, C., Sazdovitch, V., Zhao, L., Garrick, L. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804373105 · Cited by 409
Oxygen-regulated transferrin expression is mediated by hypoxia-inducible factor-1
Rolfs, A., Kvietikova, I., Gassmann, M., & Wenger, R. H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.32.20055 · Cited by 401
Smith, M. A., Zhu, X., Tabaton, M., Liu, G., McKeel, D. W., Cohen, M. L., Wang, X., Siedlak, S. L., Dwyer, B. E., Hayashi, T., et al. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1239 · Cited by 401
Perspectives in Iron Metabolism
Finch, C. A., & Huebers, H. (1982) · New England Journal of Medicine · doi:10.1056/nejm198206243062504 · Cited by 391
Gutiérrez-Solana, R. (1999) · Dialnet (Universidad de la Rioja) · Cited by 387
Structure of human lactoferrin at 3.2-A resolution.
Anderson, B. F., Baker, H. M., Dodson, E. J., Norris, G. E., Rumball, S. V., Waters, J. M., & Baker, E. N. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.7.1769 · Cited by 386
Identification of a hypoxia response element in the transferrin receptor gene
Lok, C. N., & Ponka, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.24147 · Cited by 380 · cited 1×
“…for hydroxylation of HIF-1α, any decrease in cellular iron levels will increase dimerization of HIF-1α and β and downstream transcription of target genes, which, unsurprisingly, includes those responsible for Tf (Rolfs et al., 1997), TfR1 (Lok and Ponka, 1999), and DMT1 (Lis et al., 2005).”
BackgroundCeruloplasmin regulates iron levels in the CNS and prevents free radical injury
Patel, B. N., Dunn, R. J., Jeong, S. Y., Zhu, Q., Julien, J.-P., & David, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06578.2002 · Cited by 379 · cited 1×
“Aceruloplasminemia can be recapitulated in mice that lack the Cp gene, and this can be rescued with iron chelation (Patel et al., 2002; Ayton et al., 2012b).”
BackgroundRedox-active iron mediates amyloid-β toxicity
Rottkamp, C. A., Raina, A. K., Zhu, X., Gaier, E., Bush, A. I., Atwood, C. S., Chevion, M., Perry, G., & Smith, M. A. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00494-9 · Cited by 375
Self-citationIron Deficiency Anemia in Infancy: Long-Lasting Effects on Auditory and Visual System Functioning
Algarín, C., Peirano, P., Garrido, M., Pizarro, F., & Lozoff, B. (2003) · Pediatric Research · doi:10.1203/01.pdr.0000047657.23156.55 · Cited by 375
Connor, J. R., Snyder, B. S., Beard, J. L., Fine, R. E., & Mufson, E. J. (1992) · Journal of Neuroscience Research · doi:10.1002/jnr.490310214 · Cited by 374 · cited 5×
“Both IRP1 and IRP2 are present in the rat (Siddappa et al., 2003) and human brain (Connor et al., 1992c); IRP1 has been suggested as the primary regulatory protein in the human brain and is capable of forming a double IRP1/IRE complex (Hu and Connor, 1996).”
BackgroundInfluentialRoncagliolo, M., Garrido, M., Walter, T., Peirano, P., & Lozoff, B. (1998) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/68.3.683 · Cited by 371
An American Academy of Sleep Medicine Review
Sateia, M. J., Doghramji, K., Hauri, P., & Morin, C. M. (2000) · Cited by 370
Iron deficiency and iron excess damage mitochondria and mitochondrial DNA in rats
Walter, P. B., Knutson, M. D., Paler-Martinez, A., Lee, S., Xu, Y., Viteri, F. E., & Ames, B. N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261708798 · Cited by 359
Midbrain iron content in early Parkinson disease: A potential biomarker of disease status
Martin, W. R. W., Wieler, M., & Gee, M. (2008) · Neurology · doi:10.1212/01.wnl.0000286384.31050.b5 · Cited by 354
Metallostasis in Alzheimer's disease
Ayton, S., Lei, P., & Bush, A. I. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.10.558 · Cited by 352
Self-citationVymazal, J., Righini, A., Brooks, R. A., Canesi, M., Mariani, C., Leonardi, M., & Pezzoli, G. (1999) · Radiology · doi:10.1148/radiology.211.2.r99ma53489 · Cited by 342
Iron misregulation in the brain: a primary cause of neurodegenerative disorders
Ke, Y., & Qian, Z. M. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00353-3 · Cited by 340
Transferrin and Iron in Normal, Alzheimer's Disease, and Parkinson's Disease Brain Regions
Loeffler, D. A., Connor, J. R., Juneau, P. L., Snyder, B. S., Kanaley, L., DeMaggio, A. J., Nguyen, H., Brickman, C. M., & LeWitt, P. A. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65020710.x · Cited by 334
Aisen, P. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.02.007 · Cited by 327
Iron Deficiency in Children With Attention-Deficit/Hyperactivity Disorder
Konofal, E., Lecendreux, M., Arnulf, I., & Mouren, M.-C. (2004) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.158.12.1113 · Cited by 325
The Treatment of Restless Legs Syndrome and Periodic Limb Movement Disorder
(1999) · Sleep · doi:10.1093/sleep/22.7.970 · Cited by 322
Yamamoto, A., Shin, R., Hasegawa, K., Naiki, H., Sato, H., Yoshimasu, F., & Kitamoto, T. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.t01-1-01061.x · Cited by 313
Earley, C. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmcp021288 · Cited by 309
Iron-Overload Cardiomyopathy: Pathophysiology, Diagnosis, and Treatment
Murphy, C. J., & Oudit, G. Y. (2010) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2010.05.009 · Cited by 308
Burdo, J. R., Menzies, S. L., Simpson, I. A., Garrick, L. M., Garrick, M. D., Dolan, K. G., Haile, D. J., Beard, J. L., & Connor, J. R. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1256 · Cited by 297
Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration
Miyajima, H., Nishimura, Y., Mimguchi, K., Sakamoto, M., Shimizu, T., & Honda, N. (1987) · Neurology · doi:10.1212/wnl.37.5.761 · Cited by 295
Effects of Iron Supplementation on Attention Deficit Hyperactivity Disorder in Children
Konofal, E., Lecendreux, M., Deron, J., Marchand, M., Cortese, S., Zaïm, M., Mouren, M. C., & Arnulf, I. (2008) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2007.08.014 · Cited by 292
Theil, E. C. (2004) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.24.012003.132212 · Cited by 292
CLK-1 controls respiration, behavior and aging in the nematode Caenorhabditis elegans
Felkai, S. (1999) · The EMBO Journal · doi:10.1093/emboj/18.7.1783 · Cited by 290
Neurological manifestations in Wilson's disease: Report of 119 cases
Machado, A., Fen Chien, H., Mitiko Deguti, M., Cançado, E., Soares Azevedo, R., Scaff, M., & Reis Barbosa, E. (2006) · Movement Disorders · doi:10.1002/mds.21170 · Cited by 282
Rouault, T. A., & Cooperman, S. (2006) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2006.08.002 · Cited by 280
Michaud, M., Soucy, J.-P., Chabli, A., Lavigne, G., & Montplaisir, J. (2002) · Journal of Neurology · doi:10.1007/pl00007859 · Cited by 278
Simmons, D. A., Casale, M., Alcon, B., Pham, N., Narayan, N., & Lynch, G. (2007) · Glia · doi:10.1002/glia.20526 · Cited by 277
Fleming, R. E., Migas, M. C., Holden, C. C., Waheed, A., Britton, R. S., Tomatsu, S., Bacon, B. R., & Sly, W. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040548097 · Cited by 273
The importance of non-transferrin bound iron in disorders of iron metabolism
Breuer, W., Hershko, C., & Cabantchik, Z. I. (2000) · Transfusion Science · doi:10.1016/s0955-3886(00)00087-4 · Cited by 270
Transport of Iron in the Blood‐Brain‐Cerebrospinal Fluid System
Bradbury, M. W. B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69020443.x · Cited by 270
Sequestration of iron by Lewy bodies in Parkinson's disease
Castellani, R. J., Siedlak, S. L., Perry, G., & Smith, M. A. (2000) · Acta Neuropathologica · doi:10.1007/s004010050001 · Cited by 265 · cited 1×
“Iron deposits have been found in Lewy Bodies in PD cases (Castellani et al., 2000), suggesting that α-synuclein may interact with iron at the biochemical level.”
BackgroundCeruloplasmin dysfunction and therapeutic potential for Parkinson disease
Ayton, S., Lei, P., Duce, J. A., Wong, B. X. W., Sedjahtera, A., Adlard, P. A., Bush, A. I., & Finkelstein, D. I. (2013) · Annals of Neurology · doi:10.1002/ana.23817 · Cited by 264
Self-citationPiga, A. G., Galanello, R., Forni, G. L., Cappellini, M. D., Origa, R., Zappu, A., Donato, G., Bordone, E., Lavagetto, A., Zanaboni, L., et al. (2006) · PubMed · Cited by 264
Ortiz, E., Pasquini, J. M., Thompson, K., Felt, B., Butkus, G., Beard, J., & Connor, J. R. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20207 · Cited by 260
Decreased ferritin levels in brain in Parkinson's disease
Dexter, D. T., Carayon, A., Vidailhet, M., Ruberg, M., Agid, F., Agid, Y., Lees, A. J., Wells, F. R., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb08814.x · Cited by 258
A role for heme in Alzheimer's disease: Heme binds amyloid β and has altered metabolism
Atamna, H., & Frey, W. H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404349101 · Cited by 252
MRI-determined regional brain iron concentrations in early- and late-onset restless legs syndrome
Earley, C. J., B. Barker, P., Horská, A., & Allen, R. P. (2006) · Sleep Medicine · doi:10.1016/j.sleep.2005.11.009 · Cited by 249
Brain iron metabolism and its perturbation in neurological diseases
Crichton, R. R., Dexter, D. T., & Ward, R. J. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-010-0470-z · Cited by 248
Yamamoto, A., Shin, R., Hasegawa, K., Naiki, H., Sato, H., Yoshimasu, F., & Kitamoto, T. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01061.x · Cited by 246
Huang, X., Atwood, C. S., Moir, R. D., Hartshorn, M. A., Tanzi, R. E., & Bush, A. I. (2004) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-004-0602-8 · Cited by 242
Self-citationMyelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications
Bartzokis, G., Lu, P. H., Tishler, T. A., Fong, S. M., Oluwadara, B., Finn, J. P., Huang, D., Bordelon, Y., Mintz, J., & Perlman, S. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9352-7 · Cited by 238
Ferritin, transferrin, and iron in selected regions of the adult and aged rat brain
Benkovic, S. A., & Connor, J. R. (1993) · Journal of Comparative Neurology · doi:10.1002/cne.903380108 · Cited by 238
Putative biological mechanisms of the effect of iron deficiency on brain biochemistry and behavior
Youdim, M. B., Ben-Shachar, D., & Yehuda, S. (1989) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/50.3.607 · Cited by 236
YOUDIM, M. B. H., STEPHENSON, G., & SHACHAR, D. B. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.025 · Cited by 233
Cellular iron: Ferroportin is the only way out
Ganz, T. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.02.005 · Cited by 232
Single Particle Characterization of Iron-induced Pore-forming α-Synuclein Oligomers
Kostka, M., Högen, T., Danzer, K. M., Levin, J., Habeck, M., Wirth, A., Wagner, R., Glabe, C. G., Finger, S., Heinzelmann, U., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709634200 · Cited by 226
Huntingtin: an iron-regulated protein essential for normal nuclear and perinuclear organelles
Hilditch-Maguire, P. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.19.2789 · Cited by 226
Developmental changes in transferrin and iron uptake by the brain in the rat
Taylor, E. M., & Morgan, E. H. (1990) · Developmental Brain Research · doi:10.1016/0165-3806(90)90103-6 · Cited by 221
Early childhood anemia and mild or moderate mental retardation
Hurtado, E. K., Claussen, A. H., & Scott, K. G. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.1.115 · Cited by 221
Role of the hypoxia inducible factors HIF in iron metabolism
Peyssonnaux, C., Nizet, V., & Johnson, R. S. (2008) · Cell Cycle · doi:10.4161/cc.7.1.5145 · Cited by 217 · cited 1×
“Iron metabolism is also transcriptionally regulated by the action of hypoxia inducible factors (HIFs; see Figure 2), which consists of a cytosolic protein (HIF-1α) and a nuclear HIF-1β subunit that form a DNA binding heterodimer (Peyssonnaux et al., 2008).”
BackgroundIron Promotes the Toxicity of Amyloid β Peptide by Impeding Its Ordered Aggregation
Liu, B., Moloney, A., Meehan, S., Morris, K., Thomas, S. E., Serpell, L. C., Hider, R., Marciniak, S. J., Lomas, D. A., & Crowther, D. C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.158980 · Cited by 216
Magnesium Inhibits Spontaneous and Iron-induced Aggregation of α-Synuclein
Golts, N., Snyder, H., Frasier, M., Theisler, C., Choi, P., & Wolozin, B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107866200 · Cited by 214
MRI evaluation of brain iron in earlier- and later-onset Parkinson’s disease and normal subjects
Bartzokis, G., Cummings, J. L., Markham, C. H., Marmarelis, P. Z., Treciokas, L. J., Tishler, T. A., Marder, S. R., & Mintz, J. (1999) · Magnetic Resonance Imaging · doi:10.1016/s0730-725x(98)00155-6 · Cited by 212
Expression of the iron transporter ferroportin in synaptic vesicles and the blood-brain barrier
Wu, L. J.-C., Leenders, A. G. M., Cooperman, S., Meyron-Holtz, E., Smith, S., Land, W., Tsai, R. Y. L., Berger, U. V., Sheng, Z.-H., & Rouault, T. A. (2004) · Brain Research · doi:10.1016/j.brainres.2003.10.066 · Cited by 210
The pivotal role of astrocytes in the metabolism of iron in the brain
Dringen, R., Bishop, G. M., Koeppe, M., Dang, T. N., & Robinson, S. R. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9375-0 · Cited by 209
Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation
Chinnery, P. F., Crompton, D. E., Birchall, D., Jackson, M. J., Coulthard, A., Lombes, A., Quinn, N., Wills, A., Fletcher, N., Mottershead, J. P., et al. (2006) · Brain · doi:10.1093/brain/awl319 · Cited by 205
Amyotrophic lateral sclerosis: T2 shortening in motor cortex at MR imaging.
Oba, H., Araki, T., Ohtomo, K., Monzawa, S., Uchiyama, G., Koizumi, K., Nogata, Y., Kachi, K., Shiozawa, Z., & Kobayashi, M. (1993) · Radiology · doi:10.1148/radiology.189.3.8234713 · Cited by 205
Lovell, M. A., Xiong, S., Xie, C., Davies, P., & Markesbery, W. R. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2004-6610 · Cited by 204
Brain Iron: Persistent Deficiency following Short‐term Iron Deprivation in the Young Rat
Dallman, P. R., Siimes, M. A., & Manies, E. C. (1975) · British Journal of Haematology · doi:10.1111/j.1365-2141.1975.tb00851.x · Cited by 203
Guo, C., Wang, T., Zheng, W., Shan, Z.-Y., Teng, W.-P., & Wang, Z.-Y. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.05.009 · Cited by 199
Iron(II) Binding to Amyloid-β, the Alzheimer’s Peptide
Bousejra-ElGarah, F., Bijani, C., Coppel, Y., Faller, P., & Hureau, C. (2011) · Inorganic Chemistry · doi:10.1021/ic201233b · Cited by 198
Intranigral Iron Injection Induces Behavioral and Biochemical “Parkinsonism” in Rats
Ben‐Shachar, D., & Youdim, M. B. H. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb06432.x · Cited by 197
Mitochondrial iron metabolism and its role in neurodegeneration
Horowitz, M. P., & Greenamyre, J. T. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100354 · Cited by 195
Mastroberardino, P. G., Hoffman, E. K., Horowitz, M. P., Betarbet, R., Taylor, G., Cheng, D., Na, H. M., Gutekunst, C.-A., Gearing, M., Trojanowski, J. Q., et al. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.02.009 · Cited by 195
Tau protein: Relevance to Parkinson's disease
Lei, P., Ayton, S., Finkelstein, D. I., Adlard, P. A., Masters, C. L., & Bush, A. I. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.07.016 · Cited by 191
Self-citationGuo, C., Wang, P., Zhong, M.-L., Wang, T., Huang, X.-S., Li, J.-Y., & Wang, Z.-Y. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2012.12.005 · Cited by 189
Kontoghiorghes, G. J., Aldouri, M. A., Hoffbrand, A. V., Barr, J., Wonke, B., Kourouclaris, T., & Sheppard, L. (1987) · BMJ · doi:10.1136/bmj.295.6612.1509 · Cited by 187
Alpha-Synuclein Is a Cellular Ferrireductase
Davies, P., Moualla, D., & Brown, D. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015814 · Cited by 183
Restless Legs Syndrome among Working-Aged Women
Ulfberg, J., Nyström, B., Carter, N., & Edling, C. (2001) · European Neurology · doi:10.1159/000050750 · Cited by 182
Three Histidine Residues of Amyloid-β Peptide Control the Redox Activity of Copper and Iron
Nakamura, M., Shishido, N., Nunomura, A., Smith, M. A., Perry, G., Hayashi, Y., Nakayama, K., & Hayashi, T. (2007) · Biochemistry · doi:10.1021/bi701079z · Cited by 182
α-synuclein implicated in Parkinson’s disease catalyses the formation of hydrogen peroxide in vitro
Turnbull, S., Tabner, B. J., El-Agnaf, O. M. A., Moore, S., Davies, Y., & Allsop, D. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00513-5 · Cited by 182
Crouch, P. J., Savva, M. S., Hung, L. W., Donnelly, P. S., Mot, A. I., Parker, S. J., Greenough, M. A., Volitakis, I., Adlard, P. A., Cherny, R. A., et al. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07402.x · Cited by 181
Self-citationFriedlich, A. L., Tanzi, R. E., & Rogers, J. T. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001937 · Cited by 181
MR evaluation of age-related increase of brain iron in young adult and older normal males
Bartzokis, G., Beckson, M., Hance, D. B., Marx, P., Foster, J. A., & Marder, S. R. (1997) · Magnetic Resonance Imaging · doi:10.1016/s0730-725x(96)00234-2 · Cited by 181
Reassessment of the Use of Desferrioxamine B in Iron Overload
Propper, R. D., Shurin, S. B., & Nathan, D. G. (1976) · New England Journal of Medicine · doi:10.1056/nejm197606242942603 · Cited by 180
Schneider, S. A., Hardy, J., & Bhatia, K. P. (2012) · Movement Disorders · doi:10.1002/mds.23971 · Cited by 179
GSK‐3 in Neurodegenerative Diseases
Lei, P., Ayton, S., Bush, A. I., & Adlard, P. A. (2011) · International Journal of Alzheimer’s Disease · doi:10.4061/2011/189246 · Cited by 177 · cited 1×
“…as deferoxamine can inhibit ironinduced tau hyperphosphorylation in vivo (Guo et al., 2013a), and prevention of iron uptake can also inhibit this event by deactivating glycogen synthase kinase 3 (GSK-3) and cyclin-dependent kinase 5 (Cdk-5; Xie et al., 2012), two key tau kinases (Lei et al., 2011).”
BackgroundSelf-citation1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE, AN ORALLY ACTIVE CHELATOR FOR TREATMENT OF IRON OVERLOAD
Kontoghiorghes, G., Sheppard, L., Aldouri, M., & Hoffbrand, A. V. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90545-9 · Cited by 177
Meadowcroft, M. D., Connor, J. R., Smith, M. B., & Yang, Q. X. (2009) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21731 · Cited by 176
Iron, Transferrin, and Ferritin in the Rat Brain During Development and Aging
Roskams, A. J. I., & Connor, J. R. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63020709.x · Cited by 172
Mandel, S., Maor, G., & Youdim, M. B. H. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:24:3:401 · Cited by 171
Rival, T., Page, R. M., Chandraratna, D. S., Sendall, T. J., Ryder, E., Liu, B., Lewis, H., Rosahl, T., Hider, R., Camargo, L. M., et al. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06701.x · Cited by 170
Both Iron Deficiency and Daily Iron Supplements Increase Lipid Peroxidation in Rats
Knutson, M. D., Walter, P. B., Ames, B. N., & Viteri, F. E. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.3.621 · Cited by 168
Proteome analysis of human substantia nigra in Parkinson's disease
Werner, C. J., Heyny-von Haussen, R., Mall, G., & Wolf, S. (2008) · Proteome Science · doi:10.1186/1477-5956-6-8 · Cited by 167
Khatoon, S., Grundke-Iqbal, I., & Iqbal, K. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00829-9 · Cited by 167
Wang, Y., Butros, S. R., Shuai, X., Dai, Y., Chen, C., Liu, M., Haacke, E. M., Hu, J., & Xu, H. (2011) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2765 · Cited by 167
Pfefferbaum, A., Adalsteinsson, E., Rohlfing, T., & Sullivan, E. V. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.05.006 · Cited by 165
MATTSON, M. P. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.004 · Cited by 164
The Neurological Presentation of Ceruloplasmin Gene Mutations
McNeill, A., Pandolfo, M., Kuhn, J., Shang, H., & Miyajima, H. (2008) · European Neurology · doi:10.1159/000148691 · Cited by 163
Functional roles of transferrin in the brain
Leitner, D. F., & Connor, J. R. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.10.016 · Cited by 163
Abnormal localization of iron regulatory protein in Alzheimer’s disease
Smith, M. A., Wehr, K., Harris, P. L. R., Siedlak, S. L., Connor, J. R., & Perry, G. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00002-x · Cited by 162
Rogers, J. T., Bush, A. I., Cho, H.-H., Smith, D. H., Thomson, A. M., Friedlich, A. L., Lahiri, D. K., Leedman, P. J., Huang, X., & Cahill, C. M. (2008) · Biochemical Society Transactions · doi:10.1042/bst0361282 · Cited by 162
Self-citationMRI assessment of basal ganglia iron deposition in Parkinson's disease
Wallis, L. I., Paley, M. N. J., Graham, J. M., Grünewald, R. A., Wignall, E. L., Joy, H. M., & Griffiths, P. D. (2008) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21563 · Cited by 161
Baudrexel, S., Nürnberger, L., Rüb, U., Seifried, C., Klein, J. C., Deller, T., Steinmetz, H., Deichmann, R., & Hilker, R. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.03.005 · Cited by 160
Zhu, W., Zhong, W., Wang, W., Zhan, C., Wang, C., Jianpin, Q., Wang, J., & Lei, T. (2009) · Radiology · doi:10.1148/radiol.2532082324 · Cited by 160
Alterations in Brain Transition Metals in Huntington Disease: An Evolving and Intricate Story
Rosas, H. D., Chen, Y. I., Doros, G., Salat, D. H., Chen, N.-K., Kwong, K. K., Bush, A., Fox, J., & Hersch, S. M. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.2945 · Cited by 160
Self-citationThe Role of Iron in Beta Amyloid Toxicity
Schubert, D., & Chevion, M. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2678 · Cited by 159
Zhang, J., Zhang, Y., Wang, J., Cai, P., Luo, C., Qian, Z., Dai, Y., & Feng, H. (2010) · Brain Research · doi:10.1016/j.brainres.2010.03.036 · Cited by 159
Increased murine neonatal iron intake results in Parkinson-like neurodegeneration with age
Kaur, D., Peng, J., Chinta, S. J., Rajagopalan, S., Monte, D. A. D., Cherny, R. A., & Andersen, J. K. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.04.003 · Cited by 157
Effect of prenatal iron deficiency on myelination in rat pups.
Yu, G. S., Steinkirchner, T. M., Rao, G. A., & Larkin, E. C. (1986) · PubMed Central · Cited by 156
Huntingtin-deficient zebrafish exhibit defects in iron utilization and development
Lumsden, A. L., Henshall, T. L., Dayan, S., Lardelli, M. T., & Richards, R. I. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm138 · Cited by 156
A new muscle glycogen storage disease associated with glycogenin-1 deficiency
(2014) · DIAL (Catholic University of Leuven) · doi:10.1002/ana · Cited by 155
Brain iron levels in attention-deficit/hyperactivity disorder: A pilot MRI study
Cortese, S., Azoulay, R., Castellanos, F. X., Chalard, F., Lecendreux, M., Chéchin, D., Delorme, R., Sebag, G. H., Sbarbati, A., Mouren, M., et al. (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.570376 · Cited by 151
Berg, D., Seppi, K., Behnke, S., Liepelt, I., Schweitzer, K., Stockner, H., Wollenweber, F., Gaenslen, A., Mahlknecht, P., Spiegel, J., et al. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.141 · Cited by 151
Brain iron deposits are associated with general cognitive ability and cognitive aging
Penke, L., Hernández, M. C. V., Maniega, S. M., Gow, A. J., Murray, C. L., Starr, J. M., Bastin, M. E., Deary, I. J., & Wardlaw, J. M. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.032 · Cited by 149
Moderate iron deficiency in infancy: biology and behavior in young rats
Beard, J. L., Felt, B., Schallert, T., Burhans, M., Connor, J. R., & Georgieff, M. K. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.02.024 · Cited by 146 · cited 2×
“Agreeing with complementary human studies, BID in rats causes delayed behavioral milestones (Beard et al., 2006a), including impaired memory (Yehuda et al., 1986; Wachs et al., 2005) and motor function (Hunt et al., 1994).”
BackgroundZhu, W., Xie, W., Pan, T., Xu, P., Fridkin, M., Zheng, H., Jankovic, J. J., Youdim, M. B. H., & Le, W. (2007) · The FASEB Journal · doi:10.1096/fj.07-8386com · Cited by 144
Association study between iron-related genes polymorphisms and Parkinson's disease
Borie, C., Gasparini, F., Verpillat, P., Bonnet, A.-M., Agid, Y., Hetet, G., Brice, A., Dürr, A., & Grandchamp, B. (2002) · Journal of Neurology · doi:10.1007/s00415-002-0704-6 · Cited by 143
Iron deficiency: Differential effects on monoamine transporters
Burhans, M. S., Dailey, C., Beard, Z., Wiesinger, J. A., Murray‐Kolb, L. E., Jones, B. C., & Beard, J. L. (2005) · Nutritional Neuroscience · doi:10.1080/10284150500047070 · Cited by 143
Mapping metals in Parkinson's and normal brain using rapid-scanning x-ray fluorescence
Popescu, B. F. G., George, M. J., Bergmann, U., Garachtchenko, A., Kelly, M., McCrea, R. P. E., Luening, K., Devon, R. M., George, G. N., Hanson, A. D., et al. (2009) · Physics in Medicine and Biology · doi:10.1088/0031-9155/54/3/012 · Cited by 141
Altered monamine metabolism in caudate-putamen of iron-deficient rats
Beard, J. L., Chen, Q., Connor, J. R., & Jones, B. C. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90323-9 · Cited by 140
Increased brain iron coincides with early plaque formation in a mouse model of Alzheimer's disease
Leskovjan, A. C., Kretlow, A., Lanzirotti, A., Barrea, R. A., Vogt, S., & Miller, L. M. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.11.073 · Cited by 139
Iron metabolism-new perspectives in view
Crichton, R. R., & Ward, R. J. (1992) · Biochemistry · doi:10.1021/bi00161a001 · Cited by 138
Improved T2* assessment in liver iron overload by magnetic resonance imaging
Positano, V., Salani, B., Pepe, A., Santarelli, M. F., Marchi, D. D., Ramazzotti, A., Favilli, B., Cracolici, E., Midiri, M., Cianciulli, P., et al. (2008) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2008.06.004 · Cited by 136
A histochemical study of iron‐positive cells in the developing rat brain
Connor, J. R., Pavlick, G., Karli, D. C., Menzies, S. L., & Palmer, C. (1995) · The Journal of Comparative Neurology · doi:10.1002/cne.903550112 · Cited by 136
Muñoz, P., Humeres, A., Elgueta, C., Kirkwood, A., Hidalgo, C., & Núñez, M. T. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.213785 · Cited by 135
MRI evaluation of the basal ganglia size and iron content in patients with Parkinson's disease
Kosta, P., Argyropoulou, M. I., Markoula, S., & Konitsiotis, S. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0914-9 · Cited by 135
A pilot trial of deferiprone for neurodegeneration with brain iron accumulation
Abbruzzese, G., Cossu, G., Balocco, M., Marchese, R., Murgia, D., Melis, M., Galanello, R., Barella, S., Matta, G., Ruffinengo, U., et al. (2011) · Haematologica · doi:10.3324/haematol.2011.043018 · Cited by 134
Staedt, J., Stoppe, G., Kögler, A., Riemann, H., Hajak, G., Munz, D. L., Emrich, D., & Rüther, E. (1995) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02191538 · Cited by 133
Wan, L., Nie, G., Zhang, J., Luo, Y., Zhang, P., Zhang, Z., & Zhao, B. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.10.707 · Cited by 132
Correlation of iron in the hippocampus with MMSE in patients with Alzheimer's disease
Ding, B., Chen, K., Ling, H., Sun, F., Li, X., Wan, T., Chai, W., Zhang, H., Zhan, Y., & Guan, Y. (2009) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21730 · Cited by 129 · cited 1×
“The iron content in hippocampus of patients with AD was reported to correlate with the mini-mental state examination (MMSE) and the disease duration (Ding et al., 2009; Zhu et al., 2009), suggesting that iron can play a significant role in the disease progression.”
BackgroundIncreasing striatal iron content associated with normal aging
Martin, W. R. W., Ye, F. Q., & Allen, P. S. (1998) · Movement Disorders · doi:10.1002/mds.870130214 · Cited by 129
Youdim, M. B. H., Fridkin, M., & Zheng, H. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.08.023 · Cited by 128
Moos, T., & Morgan, E. H. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02142.x · Cited by 128
Amit, T., Avramovich‐Tirosh, Y., Youdim, M. B. H., & Mandel, S. (2008) · The FASEB Journal · doi:10.1096/fj.07-8627rev · Cited by 126
Dallman, P. R., & Spirito, R. A. (1977) · Journal of Nutrition · doi:10.1093/jn/107.6.1075 · Cited by 126
Youdim, M. B. H., Fridkin, M., & Zheng, H. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0143-x · Cited by 123
Iron accumulation in the liver of male patients with Wilson's disease
Shiono, Y., Wakusawa, S., Hayashi, H., Takikawa, T., Yano, M., Okada, T., Mabuchi, H., Kono, S., & Miyajima, H. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.05269.x · Cited by 120
Lhermitte, J., Kraus, W. M., & McAlpine, D. (1924) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.s1-5.19.195 · Cited by 119
Peng, Y., Wang, C., Xu, H. H., Liu, Y., & Zhou, F. (2009) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2009.11.005 · Cited by 119
Kuhn, D. M., Ruskin, B., & Lovenberg, W. M. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85644-2 · Cited by 118
Kumar, V., Salama, A. A., Desai, B., & Kumar, N. (1988) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331758800300307 · Cited by 117
Cited by
Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics
Belaidi, A. A., & Bush, A. I. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13425 · Cited by 578
Self-citationParkinson’s Disease: Biomarkers, Treatment, and Risk Factors
Emamzadeh, F. N., & Surguchov, A. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00612 · Cited by 568
Ferroptosis and its potential role in the physiopathology of Parkinson’s Disease
Mahoney-Sánchez, L., Bouchaoui, H., Ayton, S., Devos, D., Duce, J. A., & Devedjian, J.-C. (2021) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101890 · Cited by 553
Self-citationCurrent state of Alzheimer’s fluid biomarkers
Molinuevo, J. L., Ayton, S., Batrla, R., Bednar, M. M., Bittner, T., Cummings, J., Fagan, A. M., Hampel, H., Mielke, M. M., Mikulskis, A., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1932-x · Cited by 518
Self-citationArtemisinin compounds sensitize cancer cells to ferroptosis by regulating iron homeostasis
Chen, G.-Q., Benthani, F. A., Wu, J., Liang, D., Bian, Z.-X., & Jiang, X. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-019-0352-3 · Cited by 509
Metadata
- Authors
- Hare, D., Ayton, S., Bush, A., & Lei, P.
- Venue
- Frontiers in Aging Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2013
- Volume
- 5
- Pages
- 34-34
- ISSN
- 1663-4365 (ISSN-L)
- OpenAlex
- W2114655563
- Cited by
- 443
- References
- 324
- FWCI
- 17.06
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.